UiPath stock price target raised to $14 at DA Davidson

DA Davidson raised its price target on UiPath (PATH) to $14 from $11, maintaining a Neutral rating, after the company's strong F1Q26 results which saw revenue of $357 million versus an expected $332.83 million and EPS of $0.11, exceeding the forecast of $0.10. The price target increase reflects successful Agentic product launches and a 4% stock buyback, though analysts cited competitive challenges and softness in net revenue retention as reasons for maintaining the Neutral rating; Evercore ISI also raised its price target to $15 from $11, keeping an In Line rating.

Analysis

UiPath Inc. (NYSE:PATH) demonstrated a strong start to fiscal year 2026, reporting first-quarter revenues of $357 million, surpassing the expected $332.83 million, and an earnings per share of $0.11, which exceeded the $0.10 forecast. This performance was accompanied by a 12% year-over-year increase in Annual Recurring Revenue (ARR) to $1.693 billion and operating margins reaching 20%, significantly above the anticipated 13%. The company's financial health is underscored by impressive gross profit margins of 83%, a strong cash position exceeding debt, a current ratio of 2.93x, and a minimal debt-to-equity ratio of 0.04. In response to these results and successful major Agentic product launches, DA Davidson raised its price target to $14.00 from $11.00, and Evercore ISI adjusted its target to $15.00 from $11.00. UiPath also executed a substantial share repurchase program, buying back approximately 4% of its stock (21.9 million shares at an average price of $10.40), indicating confidence in its growth trajectory. However, both DA Davidson and Evercore ISI maintained Neutral/In Line ratings, citing persistent competitive challenges and noted softness in net revenue retention (NRR) as moderating factors. Management expressed optimism regarding future deal alignments despite ongoing macroeconomic variability and provided Q2 revenue guidance of $345 million to $350 million, with full-year revenue projected between $1.549 billion and $1.554 billion. InvestingPro analysis suggests the stock is slightly undervalued, with analyst price targets generally ranging from $10.00 to $16.12.

Key Decisions for Investors

• Investors should acknowledge UiPath's robust first-quarter fiscal 2026 performance, including significant revenue and EPS beats, strong ARR growth, and substantial share buybacks, which reflect fundamental business strength and management confidence.
• It is prudent to weigh these positive financial results and product advancements against the ongoing competitive pressures and softness in net revenue retention, which are key reasons for analysts maintaining Neutral or In Line ratings despite increased price targets.
• Monitor UiPath's ability to translate its Agentic product launches and strategic partnerships into improved net revenue retention and sustained growth, particularly in achieving its stated Q2 and full-year revenue guidance amidst macroeconomic uncertainties.
• Consider UiPath's current valuation, noted by InvestingPro as slightly undervalued, alongside the revised analyst price targets and the balance between its strong financial fundamentals and the identified market headwinds before adjusting positions.